These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 9107093

  • 1. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B.
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [Abstract] [Full Text] [Related]

  • 2. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L, He X, Dahlbäck B.
    Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
    [Abstract] [Full Text] [Related]

  • 3. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B.
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [Abstract] [Full Text] [Related]

  • 4. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation.
    Váradi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP.
    Thromb Haemost; 1996 Aug; 76(2):208-14. PubMed ID: 8865533
    [Abstract] [Full Text] [Related]

  • 5. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
    van de Poel RH, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
    [Abstract] [Full Text] [Related]

  • 6. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997 May; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 7. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM, Kalafatis M, Tracy PB.
    Biochemistry; 1998 Aug 25; 37(34):11896-906. PubMed ID: 9718313
    [Abstract] [Full Text] [Related]

  • 8. Coagulation factor V: an old star shines again.
    Rosing J, Tans G.
    Thromb Haemost; 1997 Jul 25; 78(1):427-33. PubMed ID: 9198191
    [Abstract] [Full Text] [Related]

  • 9. The anticoagulant protein C pathway.
    Dahlbäck B, Villoutreix BO.
    FEBS Lett; 2005 Jun 13; 579(15):3310-6. PubMed ID: 15943976
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B, Griffin JH.
    Clin Haematol; 1985 Jun 13; 14(2):281-342. PubMed ID: 2994929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protein C.
    Esmon CT.
    Prog Hemost Thromb; 1984 Jun 13; 7():25-54. PubMed ID: 6099583
    [Abstract] [Full Text] [Related]

  • 20. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
    Evenäs P, García de Frutos P, Nicolaes GA, Dahlbäck B.
    Thromb Haemost; 2000 Aug 13; 84(2):271-7. PubMed ID: 10959700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.